1
|
Iwahashi Y, Ishida Y, Mukaida N, Kondo T. Pathophysiological Roles of the CX3CL1-CX3CR1 Axis in Renal Disease, Cardiovascular Disease, and Cancer. Int J Mol Sci 2025; 26:5352. [PMID: 40508161 PMCID: PMC12155443 DOI: 10.3390/ijms26115352] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2025] [Revised: 05/28/2025] [Accepted: 05/30/2025] [Indexed: 06/16/2025] Open
Abstract
CX3CL1 and its unique receptor, CX3CR1, are leukocyte migration factors and are involved in the pathogenesis and progression of many inflammatory diseases and malignancies. The CX3CL1-CX3CR1 axis induces a variety of responses, including cell proliferation, migration, invasion, and apoptosis resistance. CX3CL1 is a transmembrane protein, and proteolysis generates a soluble form. The membrane and soluble forms of CX3CL1 exhibit different functions, but both bind to the chemokine receptor CX3CR1. The CX3CL1-CX3CR1 axis is a chemokine system that has attracted attention not only as a therapeutic target but also as a potentially useful diagnostic and prognostic marker for disease. Many studies have reported that the CX3CL1-CX3CR1 axis is involved in disease progression, but more recently there are scattered reports suggesting that it is involved in disease suppression. In this article, we summarize the latest findings on the pathophysiological role of the CX3CL1-CX3CR1 axis, with a particular focus on renal disease, cardiovascular disease, and cancer.
Collapse
Affiliation(s)
- Yuya Iwahashi
- Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan; (Y.I.); (N.M.)
- Department of Urology, Wakayama Medical University, Wakayama 641-8509, Japan
| | - Yuko Ishida
- Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan; (Y.I.); (N.M.)
| | - Naofumi Mukaida
- Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan; (Y.I.); (N.M.)
| | - Toshikazu Kondo
- Department of Forensic Medicine, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan; (Y.I.); (N.M.)
| |
Collapse
|
2
|
Zhou R, Zou X, Yu J, Wang Z, Lu W, Li X, Wei C, Li X, Wang F. KDELR3 and YOD1 proteins as critical endoplasmic reticulum stress mediators and potential therapeutic targets in diabetic foot ulcers: An integrated bioinformatics analysis. Int J Biol Macromol 2025; 312:144095. [PMID: 40354856 DOI: 10.1016/j.ijbiomac.2025.144095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2025] [Revised: 05/06/2025] [Accepted: 05/08/2025] [Indexed: 05/14/2025]
Abstract
BACKGROUND Diabetic foot ulcers (DFU) represent one of the most severe complications of diabetes mellitus and are closely associated with persistent hyperglycemia. Endoplasmic reticulum stress response proteins play critical roles in the development and progression of DFU, highlighting the urgent need for further research to identify novel biomarkers and therapeutic strategies. METHOD This study utilized DFU datasets from the GEO database and employed bioinformatics approaches to identify differentially expressed genes encoding endoplasmic reticulum stress (ERS) response proteins. Key regulatory proteins NCCRP1, KDELR3, BOK, and YOD1 were screened using WGCNA, machine learning algorithms, and molecular docking techniques, followed by an evaluation of their correlation with the immune microenvironment. Additionally, single-cell RNA sequencing and Mendelian randomization analysis were applied to investigate the structural and functional characteristics of these proteins in DFU pathogenesis. The expression levels of key protein biomarkers were validated using qRT-PCR. RESULT A total of 32 differentially expressed endoplasmic reticulum stress-related proteins associated with DFU were identified. Machine learning algorithms confirmed that NCCRP1, KDELR3, BOK, and YOD1 proteins demonstrated significant diagnostic potential as biomarkers. Immune analysis revealed associations between these stress-response proteins and immune cell infiltration, while molecular docking identified metronidazole as a promising therapeutic candidate targeting the KDELR3 and YOD1 protein structures. Experimental validation confirmed the differential expression of KDELR3 and YOD1 proteins in DFU tissues, and Mendelian randomization analysis suggested that BOK protein may be a potential causal factor in DFU development due to its structural interactions with ERS pathways. CONCLUSION Our study characterized specific ERS response proteins with significant diagnostic potential for DFU. These findings enhance the understanding of protein-mediated DFU pathogenesis and lay the foundation for improving diagnostic and therapeutic strategies targeting these biological macromolecules.
Collapse
Affiliation(s)
- Rongbin Zhou
- Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning 530021, Guangxi, China; Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, University Engineering Research Center of Digital Medicine and Healthcare, Guangxi Medical University, Nanning 530021, Guangxi, China; Department of Urology, the Second Affiliated Hospital of Fujian Medical University, Quanzhou 362000, China
| | - Xiaochong Zou
- Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Guangxi 530021, China
| | - Jiayin Yu
- Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Guangxi 530021, China
| | - Zuheng Wang
- Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Guangxi 530021, China
| | - Wenhao Lu
- Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning 530021, Guangxi, China; Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, University Engineering Research Center of Digital Medicine and Healthcare, Guangxi Medical University, Nanning 530021, Guangxi, China
| | - Xiao Li
- School of Life Sciences, Guangxi Medical University, Nanning 530021, Guangxi, China
| | - Chunmeng Wei
- Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, University Engineering Research Center of Digital Medicine and Healthcare, Guangxi Medical University, Nanning 530021, Guangxi, China; Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Guangxi 530021, China
| | - Xing Li
- Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
| | - Fubo Wang
- Collaborative Innovation Centre of Regenerative Medicine and Medical BioResource Development and Application Co-constructed by the Province and Ministry, Guangxi Medical University, Nanning 530021, Guangxi, China; Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, University Engineering Research Center of Digital Medicine and Healthcare, Guangxi Medical University, Nanning 530021, Guangxi, China; Department of Urology, the First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Guangxi 530021, China; School of Life Sciences, Guangxi Medical University, Nanning 530021, Guangxi, China; Department of Urology, Affiliated Tumor Hospital of Guangxi Medical University, Guangxi Medical University, Nanning 530021, Guangxi, China; School of Public Health, Guangxi Medical University, Nanning 530021, Guangxi, China.
| |
Collapse
|
3
|
Gao Y, Ren J, Peng H, Nasser MI, Liu C. Follistatin-like protein 1: Implications for renal disease progression. J Pharmacol Exp Ther 2025; 392:103564. [PMID: 40239460 DOI: 10.1016/j.jpet.2025.103564] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2025] [Revised: 02/22/2025] [Accepted: 03/20/2025] [Indexed: 04/18/2025] Open
Abstract
Renal diseases, including glomerulonephritis, acute kidney injury, chronic kidney failure, and kidney tumors are all current global health challenges. Lesions in other systems can cause renal diseases and can affect other systems or even the whole body. Despite ongoing advancements in pharmaceutical and technological innovations, the prognosis for end-stage renal disease, encompassing renal failure and tumors, continues to be bleak. Follistatin-like protein 1 (FSTL1) is a secreted glycoprotein produced mainly by mesenchymal cells. FSTL1 is a glycoprotein that belongs to the family of secreted, cysteine-rich acidic proteins (SPARC). It plays a pivotal role in cell survival, proliferation, differentiation, and migration, as well as in modulating inflammation and immune responses. Research has shown that FSTL1 plays a crucial role in the onset and progression of renal diseases. This review explores the functions and underlying mechanisms of FSTL1 in kidney pathology. SIGNIFICANCE STATEMENT: This review highlights the pivotal role of FSTL1 in renal diseases, particularly its involvement in renal fibrosis, inflammation, and ischemia-reperfusion injury. By elucidating its dual roles across different pathologies, this work underscores FSTL1's potential as both a biomarker and a therapeutic target, offering novel insights for managing chronic kidney disease and associated complications.
Collapse
Affiliation(s)
- Yiqi Gao
- Tangdu Hospital of the Fourth Military Medical University, Xi'an, Shaanxi, China
| | - Junyi Ren
- University of Electronic Science and Technology of China, School of Medicine, Chengdu, Sichuan, China
| | - Haoyu Peng
- University of Electronic Science and Technology of China, School of Medicine, Chengdu, Sichuan, China
| | - Moussa Ide Nasser
- Department of Cardiac Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangdong Cardiovascular Institute, Guangzhou, Guangdong, China.
| | - Chi Liu
- Department of Nephrology, Sichuan Clinical Research Center for Kidney Disease, Sichuan Provincial People's Hospital, University of Electronic Science and Technology, Chengdu, Sichuan, China.
| |
Collapse
|
4
|
Wu J, Zeng Q, Gui S, Li Z, Miao W, Zeng M, Wang M, Hu L, Zeng G. Construction and evaluation of prediction model for postoperative re-fractures in elderly patients with hip fractures. Int J Med Inform 2025; 195:105738. [PMID: 39644793 DOI: 10.1016/j.ijmedinf.2024.105738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2024] [Revised: 11/25/2024] [Accepted: 11/28/2024] [Indexed: 12/09/2024]
Abstract
OBJECTIVE The aim of study was to construct a postoperative re-fracture prediction model for elderly hip fracture patients using an automated machine learning algorithm to provide a basis for early identification of patients with high risk of re-fracture occurrence. METHODS Clinical data were collected and subjected to univariate and multivariate analyses to determine the independent risk factors affecting postoperative re-fracture of hip fracture in the elderly. The collected data were divided into training and validation sets in a ratio of 7:3, AutoGluon was applied to construct LightGBMXT, LightGBM, RandomForestGini, RandomForestEntr, CatBoost, NeuralNetFastAI, XGBoost, NeuralNetTorch, LightGBMLarge and WeightedEnsemble_L2 prediction models, and the constructed models were evaluated using evaluation indicators. The models were externally validated and the model with the best prediction performance was selected. RESULTS The incidence of postoperative re-fracture was about 11.7%, and age, comorbid diabetes mellitus, comorbid osteoporosis, rehabilitation exercise status, and preoperative total protein level were considered as independent risk factors. The top three models in terms of AUC values in the training set were WeightedEnsemble_L2 (0.9671), XGBoost (0.9636), and LightGBM (0.9626), the WeightedEnsemble_L2 (0.9759) was best in the external validation. Based on the AUC and other evaluation indicators, WeightedEnsemble_L2 was considered the model with the best prediction performance. CONCLUSION The constructed model is highly generalizable and applicable, and can be used as an effective tool for healthcare professionals to assess and manage patients' risk of re-fracture.
Collapse
Affiliation(s)
- Jingjing Wu
- School of Nursing, Hengyang Medical School, University of South China, Hengyang, China; School-Enterprise Cooperative Innovation and Entrepreneurship Education Base, University of South China-Hunan Lantern Medical Technology Co., Ltd, Hengyang, China.
| | - Qingqing Zeng
- Jiangbei Campus of The First Affiliated Hospital of Army Medical University (The 958th Hospital of Chinese People's Liberation Army), No. 29 Jianxindong Street, Jiangbei District, Chongqing 400038, China.
| | - Sijie Gui
- Department of Orthopedics and Trauma, the First Affiliated Hospital of University of South China, Hengyang, China.
| | - Zhuolan Li
- School of Nursing, Hengyang Medical School, University of South China, Hengyang, China; School-Enterprise Cooperative Innovation and Entrepreneurship Education Base, University of South China-Hunan Lantern Medical Technology Co., Ltd, Hengyang, China.
| | - Wanyu Miao
- College of Computer Science And Engineering, Chongqing University of Technology,Chongqing , China.
| | - Mi Zeng
- School of Nursing, Hengyang Medical School, University of South China, Hengyang, China; School-Enterprise Cooperative Innovation and Entrepreneurship Education Base, University of South China-Hunan Lantern Medical Technology Co., Ltd, Hengyang, China.
| | - Manyi Wang
- School of Nursing, Hengyang Medical School, University of South China, Hengyang, China; School-Enterprise Cooperative Innovation and Entrepreneurship Education Base, University of South China-Hunan Lantern Medical Technology Co., Ltd, Hengyang, China.
| | - Li Hu
- School of Nursing, Hengyang Medical School, University of South China, Hengyang, China; School-Enterprise Cooperative Innovation and Entrepreneurship Education Base, University of South China-Hunan Lantern Medical Technology Co., Ltd, Hengyang, China.
| | - Guqing Zeng
- School of Nursing, Hengyang Medical School, University of South China, Hengyang, China; School-Enterprise Cooperative Innovation and Entrepreneurship Education Base, University of South China-Hunan Lantern Medical Technology Co., Ltd, Hengyang, China.
| |
Collapse
|